Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2009
11/12/2009US20090281162 Crystalline forms of atorvastatin
11/12/2009US20090281161 Organic Compounds
11/12/2009US20090281160 Angiotensin I-converting enzyme (ace) inhibitors
11/12/2009US20090281159 Use of hdac inhibitors for the treatment of lymphomas
11/12/2009US20090281158 Prodrugs of cc-1065 analogs
11/12/2009US20090281156 Enhancing photostabilization of oxymetazoline
11/12/2009US20090281155 Dimeric Small Molecule Potentiators of Apoptosis
11/12/2009US20090281154 Ophthalmic Compositions for Treating Ocular Hypertension
11/12/2009US20090281153 Extended Release Tablet Formulation Containing Pramipexole or a Pharmaceutically Acceptable Salt Thereof
11/12/2009US20090281152 Indole Compounds Having Affinity to the EP1 Receptor
11/12/2009US20090281150 Compound 249
11/12/2009US20090281149 Amine Derivative Compounds for Treating Ophthalmic Diseases and Disorders
11/12/2009US20090281148 treating conditions mediated by glucocorticoid receptors, such as inflammation, transplant rejection or multiple sclerosis, using 2R,4-alpha-S,10-alpha-R)-4-alpha-benzyl-7-(2-methylpyridin-3-yl)carbamoyl)-2-(trifluoromethyl)-1,2,3,4,4 alpha ,9,10,10 alpha-octahydrophenanthren-2-yl dihydrogen phosphate,
11/12/2009US20090281147 Method of treating of demyelinating diseases or conditions
11/12/2009US20090281146 Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide
11/12/2009US20090281145 Allosteric enhancers of the a1 adenosine receptor
11/12/2009US20090281144 Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors
11/12/2009US20090281143 Dose Reduction of a Cannabinoid CB1 Receptor Antagonist in the Treatment of Overweight or Obesity
11/12/2009US20090281142 Thiazole derivative
11/12/2009US20090281141 Macrocyclic inhibitors of hepatitis c virus
11/12/2009US20090281140 Macrocyclic inhibitors of hepatitis c virus
11/12/2009US20090281139 Macrocyclic factor viia inhibitors useful as anticoagulants
11/12/2009US20090281138 Bis-(Sulfonylamino) Derivatives in Therapy 066
11/12/2009US20090281137 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
11/12/2009US20090281136 Prasugrel pharmaceutical formulations
11/12/2009US20090281135 3-azabicyclo [4. 1. 0] heptane derivatives for the treatment of depression
11/12/2009US20090281134 Use of ibogamine congeners for treating obesity
11/12/2009US20090281133 Heterocyclic antiviral compounds
11/12/2009US20090281132 Pharmaceutical formulation for use in hiv therapy
11/12/2009US20090281131 Diebenzofuran derivatives as inhibitors of pde-4 and pde-10
11/12/2009US20090281130 Quinazoline derivatives
11/12/2009US20090281129 Cdki pathway inhibitors and uses thereof
11/12/2009US20090281128 Caspase inhibitors and uses thereof
11/12/2009US20090281127 Organic Compounds
11/12/2009US20090281126 Organic Compounds
11/12/2009US20090281125 Heterocyclic Compounds Useful in Treating Diseases and Conditions
11/12/2009US20090281124 4-cyanophenylamino-substituted bicyclic heterocyclic compounds as hiv inhibitors
11/12/2009US20090281123 Novel thiazolo (4,5-d) pyrimidine compounds novel compounds
11/12/2009US20090281122 Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase, and Compositions and Treatments Using the Same
11/12/2009US20090281121 SUBSTITUTED 8-PIPERIDINYL-2-PYRIDINYL-PYRIMIDO[1,2-a] PYRIMIDIN-6-ONE AND 8-PIPERIDINYL-2-PYRIMIDINYL-PYRIMIDO[1,2-a] PYRIMIDIN-6-ONE DERIVATIVES
11/12/2009US20090281120 Bicyclic heterocyclic compound
11/12/2009US20090281119 Acid addition salts of n-ethyi-n'-[2-methoxy-4-(5-methyi-4-pryimidin-2-yl)phenyl]urea and uses thereof
11/12/2009US20090281118 Selective Ligands for the Neuronal Nicotinic Receptors and Uses Thereof
11/12/2009US20090281117 1-{[2-(2,4-Difluorophenyl)-1-(3-ethoxyphenyl)-1H-imidazol-4-yl]carbonyl}-4-(2-naphthyl)piperazine, useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1R, such as obesity, and diabetes
11/12/2009US20090281116 Pyrrole derivatives, preparation thereof and therapeutic use thereof
11/12/2009US20090281115 Inhibitors of c-kit and uses thereof
11/12/2009US20090281114 Indolylalkyl derivatives of pyrimidinylpiperazine and metabolites thereof for treatment of anxiety, depression, and sexual dysfunction
11/12/2009US20090281113 Method of optimizing the treatment of philadelphia-positive leukemia with abl tyrosine kinase inhibitors
11/12/2009US20090281112 Adatanserin and metabolites thereof for treatment of attention deficit disorder, anxiety, depression, sexual dysfunction, and other disorders
11/12/2009US20090281111 3-hydroxy gepirone for the treatment of attention deficit disorder and sexual dysfunction
11/12/2009US20090281110 Method of Treatment
11/12/2009US20090281109 Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
11/12/2009US20090281108 Prenatal dietary supplement
11/12/2009US20090281107 Substituted 2,5-dihydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and therapeutic use of the same
11/12/2009US20090281106 Prophylactic and/or therapeutic method for rheumatoid arthritis
11/12/2009US20090281105 Radiotherapy enhancer
11/12/2009US20090281104 Therapeutic Compounds
11/12/2009US20090281103 Renin Inhibitors
11/12/2009US20090281102 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
11/12/2009US20090281101 5-(3-(3-(4-hexanoylphenyl)-2,5-dioxoimidazolidin-4-yl)propyl)thiophene-2-carboxylic acid; prostaglandin agonist; ocular hypotensive agent; post-sergical and post-laser trabeculectomy ocular hypertensive episodes, glaucoma, and as presurgical adjuncts
11/12/2009US20090281100 Benzimidazole quinolinones and uses thereof
11/12/2009US20090281099 Substituted pyrazinone derivatives for use as a medicine
11/12/2009US20090281098 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase
11/12/2009US20090281097 Nitrogen-containing heterocyclic compound
11/12/2009US20090281096 Cyclothiocarbamate derivatives as progesterone receptor modulators
11/12/2009US20090281095 Thiomorpholine compound and process for preparing the same
11/12/2009US20090281094 Derivatives of 1--4-methylpiperazine, synthesis process and uses thereof
11/12/2009US20090281093 Anti-inflammatory compounds
11/12/2009US20090281092 Polo-like kinase inhibitors
11/12/2009US20090281091 Methods for modulating bladder function
11/12/2009US20090281090 Biomarkers for the prediction of responsiveness to clozapine treatment
11/12/2009US20090281089 Pyridyl inhibitors of hedgehog signalling
11/12/2009US20090281088 N-{3-[3-Fluoro-4-(4-{2-[4-(2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yloxymethyl)-phenoxy]-acetyl}-piperazin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide; for prevention and treatment of bacterial infections, caused by Mycobacterium tuberculosis
11/12/2009US20090281087 Compounds II
11/12/2009US20090281086 2 -oxyheteroarylamide derivatives as parp inhibitors
11/12/2009US20090281085 3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity
11/12/2009US20090281084 peroxisome proliferator-activated receptor agonists such as 3-{2-Chloro-4-[4-morpholin-4-ylmethyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethoxy]-phenyl}-4H-[1,2,4]oxadiazol-5-one, suitable for the treatment and/or prevention of neurodegenerative diseases, metabolic and nervous system disorders
11/12/2009US20090281083 Combination Product
11/12/2009US20090281082 Polo-like kinases (Plk1); 1-[1-(2-Chlorophenyl)ethyl]-7-imidazo[1,2-a]pyridin-3-yl-1,2,3,4-tetrahydrothieno[3,2-e][1,4]diazepin-5-one; 3-iodoimidazo[1,2-a]pyridine eractant; ANTITUMOR, ANTIPROLIFERATIVE
11/12/2009US20090281081 Chemokine receptor antagonists and methods of use therefor
11/12/2009US20090281080 Spirohydantoin Tricyclic CGRP Receptor Antagonists
11/12/2009US20090281079 Substituted 4-Amino-Pyrrolotriazine Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated With Angiogenesis
11/12/2009US20090281078 Combination of sabcomeline with a neuroleptic agent to treat psychotic disorders
11/12/2009US20090281077 Cyclic sulfones useful as mitochondrial sodium-calcium exchangers
11/12/2009US20090281076 Azetidine Derivatives as G-Protein Coupled Receptor (GPR119) Agonists
11/12/2009US20090281075 Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors
11/12/2009US20090281074 Drug compositions and methods for preventing and treating thrombosis or embolism
11/12/2009US20090281073 Heteroaromatic derivatives useful as anticancer agents
11/12/2009US20090281072 Diaminopyrimidinecarboxamide Derivative
11/12/2009US20090281071 Therapeutic agent for hypertension
11/12/2009US20090281070 Method for Preparing a Solid Pharmaceutical Composition with Sustained and Controlled Release by High Pressure Treatment
11/12/2009US20090281069 Organic compounds
11/12/2009US20090281068 Polylactide compositions and uses thereof
11/12/2009US20090281067 Nitroxyl progenitor compounds and methods of use
11/12/2009US20090281066 Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones
11/12/2009US20090281065 Use of Lysophospholipids to Treat Inflammation
11/12/2009US20090281064 Solid pharmaceutical dosage forms comprising bisphosphonates and modified amino acid carriers
11/12/2009US20090281063 Iontophoretic preparation for treatment of breast cancer and/or mastitis
11/12/2009US20090281062 Novel nitroso compounds as nitroxyl donors and methods of use thereof
11/12/2009US20090281061 Impaired Alleles of Genes Involved in Metabolic Pathways and Methods for Detecting and Using the Same
1 ... 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 ... 7860